- March 14, 2019
US FDA allows marketing of new device to help treat carbon monoxide poisoning
The U.S. Food and Drug Administration today allowed marketing of a new device, ClearMate, intended to be used in an emergency room setting to help treat patients suffering from carbon monoxide poisoning. The device uses a novel method for quickly removing carbon monoxide from the body by increasing a patient’s rate of breathing.
CONTINUE READING ON www.fda.gov